Oncology Practice Management Issues


January 2017, Vol 7, No 1

Comparing the Current Value Frameworks in Oncology

Meg Barbor, MPH

Value-Based Care

Value frameworks in oncology are relatively early in development, and their ultimate impact remains unknown, but at a minimum, providers should be aware of the current value frameworks and how each value framework measures value, as well as their implications for clinical trial development, said Kasia Shields, PharmD, MBA, BCOP, BCPS, Director, Medical Communications, Xcenda/AmerisourceBergen, at the 2016 Hematology/Oncology Pharmacy Association Oncology Pharmacy Practice Management Program. [ Read More ]

FDA News – January 2017

FDA News

In This Article Rubraca Approved for Advanced Ovarian Cancer with BRCA Mutations Avastin Approved for Platinum-Sensitive Ovarian Cancer Darzalex Approved for Use in Combination with Standard Regimen for Multiple Myeloma Opdivo Now Approved for Head and Neck Squamous-Cell Carcinoma Rubraca [ Read More ]